Research programme: hormone therapies - Viramal

Drug Profile

Research programme: hormone therapies - Viramal

Alternative Names: Progestin-only contraceptive

Latest Information Update: 03 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Viramal
  • Class Hormonal contraceptives; Hormones
  • Mechanism of Action Estrogen receptor agonists; Estrogen receptor antagonists; Progesterone receptor agonists; Progesterone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Endometriosis; Menopausal syndrome; Pregnancy

Most Recent Events

  • 28 Nov 2017 Viramal plans a phase II trial of vaginal danazol versus oral danazol for Endometriosis in November 2017 (NCT03352076)
  • 24 May 2016 Preclinical trials in Endometriosis in United Kingdom (Vaginal) before May 2016
  • 24 May 2016 Preclinical trials in Menopausal syndrome in United Kingdom (Transdermal, Topical) before May 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top